Eugene Andrew Bauer
Co-Founder, Chief Medical Officer & DirectorDr. Eugene Andrew Bauer, also known as Gene, M.D., served as Independent Director at Applied UV, Inc since 2020 until May 17, 2022. He serves as Director at First Wave Technologies, Inc. since 2020. He co-founded Dermira, Inc. in August 2010 and served as its Chief Medical Officer since October 2011 until March 2020. Dr. Bauer has been a Consultant of Medgenics, Inc. since June 30, 2012. He was a Founder and Consultant of Connetics Corporation since 1993. He co-founded Evommune, Inc. He is Chief Medical Officer of Evommune, Inc. since April 2020 and serves as its Director since April 2020. He has been a Lucy Becker Professor Emeritus of Dermatology at The Leland Stanford Junior University since 2002. Dr. Bauer is Professor Emeritus at Stanford University School of Medicine, a position he has held since 2002. He was the President, Chief Medical Officer and Executive Director at Peplin Inc. He served as a Vice President for Medical Affairs and Dean of the Stanford University School of Medicine from 1995 to 2001 and served as the Chairman of the Department of Dermatology at the Stanford University School of Medicine from 1988 to 1995. Dr. Bauer served as the Chief Medical Officer and President of Peplin, Inc. since August 18, 2008. Dr. Bauer served as the Chief Executive Officer and President at Neosil, Inc. from November 2004 to October 2008. He served as a Program Director of the Stanford University General Clinical Research Center. He has been the Chairman and Director at Dr. Tattoff, Inc. since August 2010. He served as the Chairman and Member of Scientific Advisory Board of WaferGen Bio-systems, Inc. since June 2007. He served as the Chairman of PROLOR Biotech, Inc. from 2005 to March 2008. He served as the Chairman of Cerecor, Inc. until January 10, 2012 and served as its Director until October 18, 2017. He served as a Non-Executive Chairman of Medgenics, Inc. from July 2005 to June 30, 2012. He served as the Chairman of Vyteris, Inc. He served as an Executive Chairman of Aevi Genomic Medicine, Inc. from October 18, 2010 to June 30, 2012 and had been its Director since March 2001 until February 3, 2020. He serves as a Director of BayBio, Neosil, Inc. He has been an Independent Director of Kadmon Holdings, Inc. since 2010. He served as a Director of Dermira, Inc. since August 2010 until February 19, 2020. Dr. Bauer served as a Member of Strategic Advisory Board at Medgenics, Inc. He served as an Executive Director of Peplin, Inc. since June 24, 2006. He served as a Director of PROLOR Biotech, Inc. until March 2008. He served as a Director of Protalex Inc. from February 15, 2005 to November 2009. He served as a Member of Scientific and Medical Advisory Board at Medgenics, Inc. He served as a Director of Medisync Bioservices Inc. He served as an Independent Director of Echo Healthcare Acquisition Corp. He served as a Director Emeritus of Connetics Corporation since October 2006 and served as its Director from 1990 to 2006. He served as a Director of Patient Safety Technologies, Inc. from January 26, 2010 to June 2010. He served as a Director of Arbor Vita Corporation, Bay Area Bioscience Association and Pet DRx Corporation. Dr. Bauer served as Director, President and Chief Medical Officer of Pelpin, Inc., a publicly traded specialty pharmaceutical company, from 2008 to 2010. He is Member of numerous honorific societies, including the National Academy of Medicine. Dr. Bauer was a U.S. National Institute of Health (NIH)-funded investigator and served on review groups for the NIH. Dr. Bauer was elected to several societies including the Institute of Medicine of the National Academy of Sciences. He has also been honored by the Society for Investigative Dermatology (Montagna Award and Stephen Rothman Memorial Award), by the American Academy of Dermatology (Sulzberger Award) and by Northwestern University (Alumni Merit and Distinguished Alumnus Awards). Dr. Bauer received a B.S. in Medicine from Northwestern University and M.D from Northwestern University Medical School.
Positions
- Company NameEvommune, Inc.Stock CodeEVMNPositionCo-Founder, Chief Medical Officer & DirectorColleagues
- LCLuis C. PenaFounder, President, CEO & Director
- BFBenjamin F. McGrawIndependent Chairman of the Board
- KCKyle CarverChief Financial Officer
- GSGregory S. MossChief Business & Legal Officer, Corporate Secretary and Chief Compliance Officer
- JPJeegar PatelChief Scientific Officer
- DEDavid Eric CohenIndependent Director
- ASArthur S. KirschIndependent Director
